Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Anus Neoplasms × Radiation × Clear all

Phase

Phase 2 4 Phase 3 2 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 2 Carcinoma 2 Stomach Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Perivascular Epithelioid Cell Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Mucositis 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Head and Neck Neoplasms 1 Granuloma, Plasma Cell 1 Gliosarcoma 1 Fibrosarcoma 1 Extensive Stage Lung Small Cell Carcinoma 1 Esophageal Squamous Cell Carcinoma 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1

Interventions

Mitomycin 2 Radiotherapy 1 Radiation 1 Fluorouracil 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05902533 2025-12-18

REDEL

University of Cincinnati

Phase 2/3 Active not recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡